{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:51:36Z","timestamp":1790787096892,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T00:00:00Z","timestamp":1571011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T00:00:00Z","timestamp":1571011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Trauma Emerg Surg"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s00068-019-01240-z","type":"journal-article","created":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T04:31:18Z","timestamp":1571027478000},"page":"573-580","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Fractures in Parkinson\u2019s Disease: injury patterns, hospitalization, and therapeutic aspects"],"prefix":"10.1007","volume":"47","author":[{"given":"Nils","family":"M\u00fchlenfeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"S\u00f6hling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo","family":"Marzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Pieper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Paule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp S.","family":"Reif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Strzelczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1086-4016","authenticated-orcid":false,"given":"Ren\u00e9 D.","family":"Verboket","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent M.","family":"Willems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,14]]},"reference":[{"key":"1240_CR1","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"LML de Lau","year":"2006","unstructured":"de Lau LML, Breteler MMB. Epidemiology of Parkinson's disease. Lancet Neurol. 2006;5:525\u201335.","journal-title":"Lancet Neurol"},{"issue":"5","key":"1240_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.4236\/ojpm.2015.55023","volume":"5","author":"A Gaba","year":"2015","unstructured":"Gaba A. Recent studies on nutrition and Parkinson's disease prevention: a systematic review. Open J Prev Med. 2015;5(5):197\u2013205.","journal-title":"Open J Prev Med."},{"key":"1240_CR3","first-page":"146","volume":"22","author":"P Martinez-Martin","year":"2018","unstructured":"Martinez-Martin P, Macaulay D, Jalundhwala YJ, Mu F, Ohashi E, Marshall T, et al. The long-term direct and indirect economic burden among Parkinson's disease caregivers in the United States. Mov Disord. 2018;22:146.","journal-title":"Mov Disord"},{"key":"1240_CR4","doi-asserted-by":"publisher","first-page":"j1951","DOI":"10.1136\/bmj.j1951","volume":"358","author":"G Rogers","year":"2017","unstructured":"Rogers G, Davies D, Pink J, Cooper P. Parkinson's disease: summary of updated NICE guidance. BMJ. 2017;358:j1951.","journal-title":"BMJ"},{"key":"1240_CR5","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1093\/ageing\/afp137","volume":"38","author":"S Abou-Raya","year":"2009","unstructured":"Abou-Raya S, Helmii M, Abou-Raya A. Bone and mineral metabolism in older adults with Parkinson's disease. Age Ageing. 2009;38:675\u201380.","journal-title":"Age Ageing"},{"key":"1240_CR6","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1007\/s00415-005-0855-3","volume":"252","author":"Y Balash","year":"2005","unstructured":"Balash Y, Peretz C, Leibovich G, Herman T, Hausdorff JM, Giladi N. Falls in outpatients with Parkinson's disease: frequency, impact and identifying factors. J Neurol. 2005;252:1310\u20135.","journal-title":"J Neurol"},{"key":"1240_CR7","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1007\/s004150170047","volume":"248","author":"BR Bloem","year":"2001","unstructured":"Bloem BR, Grimbergen YA, Cramer M, Willemsen M, Zwinderman AH. Prospective assessment of falls in Parkinson's disease. J Neurol. 2001;248:950\u20138.","journal-title":"J Neurol"},{"key":"1240_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1600-0404.2010.01386.x","volume":"123","author":"M Matinolli","year":"2011","unstructured":"Matinolli M, Korpelainen JT, Sotaniemi KA, Myllyl\u00e4 VV, Korpelainen R. Recurrent falls and mortality in Parkinson's disease: a prospective two-year follow-up study. Acta Neurol Scand. 2011;123:193\u2013200.","journal-title":"Acta Neurol Scand"},{"key":"1240_CR9","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1002\/mds.21598","volume":"22","author":"RM Pickering","year":"2007","unstructured":"Pickering RM, Grimbergen YAM, Rigney U, Ashburn A, Mazibrada G, Wood B, et al. A meta-analysis of six prospective studies of falling in Parkinson's disease. Mov Disord. 2007;22:1892\u2013900.","journal-title":"Mov Disord"},{"key":"1240_CR10","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/mds.20347","volume":"20","author":"CL Wielinski","year":"2005","unstructured":"Wielinski CL, Erickson-Davis C, Wichmann R, Walde-Douglas M, Parashos SA. Falls and injuries resulting from falls among patients with Parkinson's disease and other parkinsonian syndromes. Mov Disord. 2005;20:410\u20135.","journal-title":"Mov Disord"},{"key":"1240_CR11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.parkreldis.2018.06.020","volume":"56","author":"AH Tan","year":"2018","unstructured":"Tan AH, Hew YC, Lim S-Y, Ramli NM, Kamaruzzaman SB, Tan MP, et al. Altered body composition, sarcopenia, frailty, and their clinico-biological correlates, in Parkinson's disease. Parkinsonism Relat Disord. 2018;56:58\u201364.","journal-title":"Parkinsonism Relat Disord."},{"key":"1240_CR12","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/ene.13238","volume":"24","author":"SS Paul","year":"2017","unstructured":"Paul SS, Harvey L, Canning CG, Boufous S, Lord SR, Close JCT, et al. Fall-related hospitalization in people with Parkinson's disease. Eur J Neurol. 2017;24:523\u20139.","journal-title":"Eur J Neurol"},{"key":"1240_CR13","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.parkreldis.2014.01.022","volume":"20","author":"M Braga","year":"2014","unstructured":"Braga M, Pederzoli M, Antonini A, Beretta F, Crespi V. Reasons for hospitalization in Parkinson's disease: a case-control study. Parkinsonism Relat Disord. 2014;20:488\u201392 (discussion 488).","journal-title":"Parkinsonism Relat Disord"},{"issue":"8","key":"1240_CR14","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/j.1445-5994.2006.01123.x","volume":"36","author":"JA Temlett","year":"2006","unstructured":"Temlett JA, Thompson PD. Reasons for admission to hospital for Parkinson's disease. Intern Med J. 2006;36(8):524\u20136.","journal-title":"Intern Med J."},{"key":"1240_CR15","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/ageing\/afy059","volume":"47","author":"SR Lord","year":"2018","unstructured":"Lord SR, Close JCT. New horizons in fall prevention. Age Ageing. 2018;47:492\u20138.","journal-title":"Age Ageing"},{"key":"1240_CR16","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1007\/s00198-010-1455-3","volume":"22","author":"MEL Arbouw","year":"2011","unstructured":"Arbouw MEL, Movig KLL, van Staa TP, Egberts ACG, Souverein PC, de Vries F. Dopaminergic drugs and the risk of hip or femur fracture: a population-based case-control study. Osteoporos Int. 2011;22:2197\u2013204.","journal-title":"Osteoporos Int"},{"key":"1240_CR17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/9781118715598.ch17","volume-title":"STROBE (STrengthening the Reporting of Observational studies in Epidemiology). Guidelines for Reporting Health Research: a user's manual","author":"M Cevallos","year":"2014","unstructured":"Cevallos M, Egger M. STROBE (STrengthening the Reporting of Observational studies in Epidemiology). Guidelines for Reporting Health Research: a user's manual. Oxford: Wiley; 2014. p. 169\u2013179."},{"key":"1240_CR18","first-page":"2","volume":"3","author":"K Harron","year":"2018","unstructured":"Harron K, Benchimol E, Langan S. Using the RECORD guidelines to improve transparent reporting of studies based on routinely collected data. Int J Popul Data Sci. 2018;3:2.","journal-title":"Int J Popul Data Sci"},{"issue":"Suppl 2","key":"1240_CR19","doi-asserted-by":"publisher","first-page":"S235","DOI":"10.1097\/BCR.0000000000000076","volume":"35","author":"S Taylor","year":"2014","unstructured":"Taylor S, Curri T, Lawless M, Sen S, Greenhalgh DG, Palmieri TL. Predicting resource utilization in burn treatment. J Burn Care Res. 2014;35(Suppl 2):S235\u2013S246246.","journal-title":"J Burn Care Res"},{"key":"1240_CR20","unstructured":"Human male skeleton. Edited from LadyofHats Mariana Ruiz Villarreal. https:\/\/commons.wikimedia.org\/wiki\/File:Human_skeleton_front_no-text_no-color.svg. Accessed 02 Feb 2019."},{"issue":"4","key":"1240_CR21","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1093\/gerona\/glx254","volume":"74","author":"S Del Din","year":"2019","unstructured":"Del Din S, Galna B, Godfrey A, et al. Analysis of free-living gait in older adults with and without Parkinson's disease and with and without a history of falls: identifying generic and disease-specific characteristics. J Gerontol A Biol Sci Med Sci. 2019;74(4):500\u20136.","journal-title":"J Gerontol A Biol Sci Med Sci."},{"key":"1240_CR22","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1136\/jnnp-2013-307307","volume":"85","author":"KM Torsney","year":"2014","unstructured":"Torsney KM, Noyce AJ, Doherty KM, Bestwick JP, Dobson R, Lees AJ. Bone health in Parkinson's disease: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2014;85:1159\u201366.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1240_CR23","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.parkreldis.2010.11.009","volume":"17","author":"MJ Aminoff","year":"2011","unstructured":"Aminoff MJ, Christine CW, Friedman JH, Chou KL, Lyons KE, Pahwa R, et al. Management of the hospitalized patient with Parkinson's disease: current state of the field and need for guidelines. Parkinsonism Relat Disord. 2011;17:139\u201345.","journal-title":"Parkinsonism Relat Disord"},{"key":"1240_CR24","doi-asserted-by":"publisher","first-page":"e97073","DOI":"10.1371\/journal.pone.0097073","volume":"9","author":"P Benzinger","year":"2014","unstructured":"Benzinger P, Rapp K, Maetzler W, K\u00f6nig H-H, Jaensch A, Klenk J, et al. Risk for femoral fractures in Parkinson's disease patients with and without severe functional impairment. Toft M, editor. PLoS ONE. 2014;9:e97073.","journal-title":"PLoS ONE"},{"key":"1240_CR25","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1002\/mds.20946","volume":"21","author":"LJ Melton","year":"2006","unstructured":"Melton LJ, Leibson CL, Achenbach SJ, Bower JH, Maraganore DM, Oberg AL, et al. Fracture risk after the diagnosis of Parkinson's disease: influence of concomitant dementia. Mov Disord. 2006;21:1361\u20137.","journal-title":"Mov Disord"},{"key":"1240_CR26","doi-asserted-by":"publisher","first-page":"351","DOI":"10.5301\/hip.2011.8402","volume":"21","author":"KG Yiannopoulou","year":"2011","unstructured":"Yiannopoulou KG, Papageorgiou SG, Anastasiou IP, Ganetsos TK, Karydakis KD. Prevalence of Parkinsonism in older patients with hip fracture. Hip Int. 2011;21:351\u20135.","journal-title":"Hip Int"},{"key":"1240_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2018.07.008","volume":"57","author":"MW Creaby","year":"2018","unstructured":"Creaby MW, Cole MH. Gait characteristics and falls in Parkinson's disease: a systematic review and meta-analysis. Parkinsonism Relat Disord. 2018;57:1\u20138.","journal-title":"Parkinsonism Relat Disord"},{"key":"1240_CR28","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1007\/s10072-018-3480-5","volume":"39","author":"S Tomic","year":"2018","unstructured":"Tomic S, Pekic V, Popijac Z, Pucic T, Vinkovic MP, Kuric TG, et al. Hyperhomocysteinemia influenced malnutrition in Parkinson's disease patients. Neurol Sci. 2018;39:1691\u20135.","journal-title":"Neurol Sci"},{"key":"1240_CR29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3340\/jkns.2018.0012","volume":"62","author":"JY Lee","year":"2019","unstructured":"Lee JY, Lim NG, Chung CK, Lee J-Y, Kim HJ, Park SB. Parkinson's disease as risk factor in osteoporosis and osteoporotic vertebral fracture prevalence study using national inpatient sample database in Korea. J Korean Neurosurg Soc. 2019;62:71\u201382.","journal-title":"J Korean Neurosurg Soc"},{"key":"1240_CR30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3233\/JPD-150615","volume":"6","author":"LM Rimmelzwaan","year":"2016","unstructured":"Rimmelzwaan LM, van Schoor NM, Lips P, Berendse HW, Eekhoff EMW. Systematic review of the relationship between vitamin D and Parkinson's disease. J Parkinsons Dis. 2016;6:29\u201337.","journal-title":"J Parkinsons Dis"},{"key":"1240_CR31","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1080\/00207454.2016.1206897","volume":"127","author":"C Tassorelli","year":"2017","unstructured":"Tassorelli C, Berlangieri M, Buscone S, Bolla M, De Icco R, Baricich A, et al. Falls, fractures and bone density in Parkinson's disease\u2014a cross-sectional study. Int J Neurosci. 2017;127:299\u2013304.","journal-title":"Int J Neurosci"},{"key":"1240_CR32","first-page":"475","volume":"55","author":"RD Verboket","year":"2018","unstructured":"Verboket RD, S\u00f6hling N, Marzi I, Paule E, Knake S, Rosenow F, et al. Prevalence, risk factors and therapeutic aspects of injuries and accidents in women with epilepsy. Eur J Trauma Emerg Surg. 2018;55:475\u20137.","journal-title":"Eur J Trauma Emerg Surg"},{"key":"1240_CR33","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.msard.2019.01.022","volume":"28","author":"EJ Bisson","year":"2019","unstructured":"Bisson EJ, Ekuma O, Marrie RA, Leslie WD, Finlayson ML. Factors associated with receiving bone mineral density screening among people with multiple sclerosis. Mult Scler Relat Disord. 2019;28:305\u20138.","journal-title":"Mult Scler Relat Disord"},{"key":"1240_CR34","first-page":"54","volume":"8","author":"A Strzelczyk","year":"2017","unstructured":"Strzelczyk A, Griebel C, Lux W, Rosenow F, Reese J-P. The burden of severely drug-refractory epilepsy: a comparative longitudinal evaluation of mortality, morbidity, resource use, and cost using german health insurance data. Front Neurol Front. 2017;8:54.","journal-title":"Front Neurol Front"},{"key":"1240_CR35","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00068-019-01162-w","volume":"45","author":"C Seebach","year":"2019","unstructured":"Seebach C, Verboket R. Consequences and treatment aspects of trauma in female patients. Eur J Trauma Emerg Surg. 2019;45:373\u20134.","journal-title":"Eur J Trauma Emerg Surg"},{"key":"1240_CR36","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3389\/fneur.2018.00414","volume":"9","author":"LM Willems","year":"2018","unstructured":"Willems LM, Watermann N, Richter S, et al. Incidence, risk factors and consequences of epilepsy-related injuries and accidents: A retrospective, single center study. Front Neurol. 2018;9:414.","journal-title":"Front Neurol."},{"key":"1240_CR37","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jbspin.2015.03.009","volume":"82","author":"S Malochet-Guinamand","year":"2015","unstructured":"Malochet-Guinamand S, Durif F, Thomas T. Parkinson's disease: A risk factor for osteoporosis. Jt Bone Spine. 2015;82:406\u201310.","journal-title":"Jt Bone Spine"},{"key":"1240_CR38","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1373\/clinchem.2005.053363","volume":"51","author":"M Herrmann","year":"2005","unstructured":"Herrmann M, Widmann T, Colaianni G, Colucci S, Zallone A, Herrmann W. Increased osteoclast activity in the presence of increased homocysteine concentrations. Clin Chem Clin Chem. 2005;51:2348\u201353.","journal-title":"Clin Chem Clin Chem"},{"key":"1240_CR39","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1359\/jbmr.060406","volume":"21","author":"J-M Koh","year":"2006","unstructured":"Koh J-M, Lee Y-S, Kim YS, Kim DJ, Kim H-H, Park J-Y, et al. Homocysteine enhances bone resorption by stimulation of osteoclast formation and activity through increased intracellular ROS generation. J Bone Miner Res. 2006;21:1003\u2013111.","journal-title":"J Bone Miner Res"},{"key":"1240_CR40","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.jocd.2011.12.001","volume":"15","author":"A El Maghraoui","year":"2012","unstructured":"El Maghraoui A, Ghozlani I, Mounach A, Rezqi A, Oumghar K, Achemlal L, et al. Homocysteine, folate, and vitamin B12 levels and vertebral fracture risk in postmenopausal women. J Clin Densitom. 2012;15:328\u201333.","journal-title":"J Clin Densitom"},{"key":"1240_CR41","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s10654-017-0321-4","volume":"32","author":"MA Ikram","year":"2017","unstructured":"Ikram MA, Brusselle GGO, Murad SD, van Duijn CM, Franco OH, Goedegebure A, et al. The Rotterdam Study: 2018 update on objectives, design and main results. Eur J Epidemiol. 2017;32:807\u201350.","journal-title":"Eur J Epidemiol"},{"key":"1240_CR42","doi-asserted-by":"crossref","unstructured":"Neue Osteoporose-Leitlinie und Patienteninformation. J Miner Stoffwechs. Muskuloskelet. Erkrank. Springer Vienna. 2018;25:75\u20136.","DOI":"10.1007\/s41970-018-0030-9"},{"key":"1240_CR43","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3945\/ajcn.112.051664","volume":"97","author":"M Suzuki","year":"2013","unstructured":"Suzuki M, Yoshioka M, Hashimoto M, Murakami M, Noya M, Takahashi D, et al. Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease. Am J Clin Nutr. 2013;97:1004\u2013133.","journal-title":"Am J Clin Nutr"},{"key":"1240_CR44","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1016\/j.biomaterials.2012.01.020","volume":"33","author":"AMC Barradas","year":"2012","unstructured":"Barradas AMC, Fernandes HAM, Groen N, Chai YC, Schrooten J, van de Peppel J, et al. A calcium-induced signaling cascade leading to osteogenic differentiation of human bone marrow-derived mesenchymal stromal cells. Biomaterials. 2012;33:3205\u201315.","journal-title":"Biomaterials"},{"key":"1240_CR45","doi-asserted-by":"publisher","first-page":"e39227","DOI":"10.1371\/journal.pone.0039227","volume":"7","author":"ED Dean","year":"2012","unstructured":"Dean ED, Mexas LM, C\u00e1piro NL, McKeon JE, DeLong MR, Pennell KD, et al. 25-Hydroxyvitamin D depletion does not exacerbate MPTP-induced dopamine neuron damage in mice. Block ML, editor. PLoS ONE. 2012;7:e39227.","journal-title":"PLoS ONE"},{"key":"1240_CR46","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0006-8993(01)02450-7","volume":"904","author":"JY Wang","year":"2001","unstructured":"Wang JY, Wu JN, Cherng TL, Hoffer BJ, Chen HH, Borlongan CV, et al. Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats. Brain Res. 2001;904:67\u201375.","journal-title":"Brain Res"},{"key":"1240_CR47","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.parkreldis.2004.07.008","volume":"11","author":"S Zoccolella","year":"2005","unstructured":"Zoccolella S, Lamberti P, Armenise E, de Mari M, Lamberti SV, Mastronardi R, et al. Plasma homocysteine levels in Parkinson's disease: role of antiparkinsonian medications. Parkinsonism Relat Disord. 2005;11:131\u20133.","journal-title":"Parkinsonism Relat Disord"},{"key":"1240_CR48","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1002\/mds.21659","volume":"22","author":"O Moore","year":"2007","unstructured":"Moore O, Peretz C, Giladi N. Freezing of gait affects quality of life of peoples with Parkinson's disease beyond its relationships with mobility and gait. Mov Disord. 2007;22:2192\u20135.","journal-title":"Mov Disord"},{"key":"1240_CR49","unstructured":"Ld D. Idiopathisches Parkinson-Syndrom, Entwicklungsstufe: S3, Stand: 1. Januar 2016, G\u00fcltig bis: 31. Dezember 2020, AWMF-Registernummer: 030\/010. 2016."},{"key":"1240_CR50","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1093\/neuros\/nyx602","volume":"83","author":"NJ Brandmeir","year":"2018","unstructured":"Brandmeir NJ, Brandmeir CL, Carr D, Kuzma K, McInerney J. Deep brain stimulation for Parkinson disease does not worsen or improve postural instability: a prospective cohort trial. Neurosurgery. 2018;83:1173\u201382.","journal-title":"Neurosurgery"},{"key":"1240_CR51","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3233\/NRE-2005-20305","volume":"20","author":"EJ Protas","year":"2005","unstructured":"Protas EJ, Mitchell K, Williams A, Qureshy H, Caroline K, Lai EC. Gait and step training to reduce falls in Parkinson's disease. NeuroRehabilitation. 2005;20:183\u201390.","journal-title":"NeuroRehabilitation"},{"key":"1240_CR52","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/978-3-319-72736-3_10","volume-title":"Rehabilitation of Parkinson\u2019s disease advanced technologies for the rehabilitation of gait and balance disorders","author":"G Abbruzzese","year":"2018","unstructured":"Abbruzzese G, Pelosin E. Rehabilitation of Parkinson\u2019s disease advanced technologies for the rehabilitation of gait and balance disorders. Cham: Springer International Publishing; 2018. p. 161\u2013170."},{"key":"1240_CR53","first-page":"269215518788615","volume":"33","author":"MH Thaut","year":"2018","unstructured":"Thaut MH, Rice RR, Braun Janzen T, Hurt-Thaut CP, McIntosh GC. Rhythmic auditory stimulation for reduction of falls in Parkinson's disease: a randomized controlled study. Clin Rehabil. 2018;33:269215518788615\u201343.","journal-title":"Clin Rehabil"},{"key":"1240_CR54","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13063-018-3123-4","volume":"20","author":"M-G Kang","year":"2019","unstructured":"Kang M-G, Yun SJ, Shin HI, Kim E, Lee HH, Oh B-M, et al. Effects of robot-assisted gait training in patients with Parkinson's disease: study protocol for a randomized controlled trial. Trials. 2019;20:15.","journal-title":"Trials"},{"key":"1240_CR55","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.3390\/s18103549","volume":"18","author":"M Zhang","year":"2018","unstructured":"Zhang M, Artan NS, Gu H, Dong Z, Burina Ganatra L, Shermon S, et al. Gait Study of Parkinson's disease subjects using haptic cues with a motorized walker. Sensors (Basel). 2018;18:3549.","journal-title":"Sensors (Basel)"},{"key":"1240_CR56","first-page":"CD001255","volume":"32","author":"N Santesso","year":"2014","unstructured":"Santesso N, Carrasco-Labra A, Brignardello-Petersen R. Hip protectors for preventing hip fractures in older people. Cochrane Bone, Joint and Muscle Trauma Group, editor. Cochrane Database Syst Rev. 2014;32:CD001255.","journal-title":"Cochrane Database Syst Rev"}],"container-title":["European Journal of Trauma and Emergency Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00068-019-01240-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00068-019-01240-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00068-019-01240-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T16:06:51Z","timestamp":1695312411000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00068-019-01240-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,14]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["1240"],"URL":"https:\/\/doi.org\/10.1007\/s00068-019-01240-z","relation":{},"ISSN":["1863-9933","1863-9941"],"issn-type":[{"value":"1863-9933","type":"print"},{"value":"1863-9941","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,14]]},"assertion":[{"value":"10 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"I. Marzi reports grants from AO foundation and Deutsche Forschungsgemeinschaft. A. Strzelczyk reports personal fees and grants from Desitin Arzneimittel, Eisai, GW pharma, LivaNova, Medtronic, Sage Therapeutics, UCB Pharma, and Zogenix.N. M\u00fchlenfeld, R.D. Verboket, N. S\u00f6hling, M. Pieper, E. Paule, P.S. Reif, and L.M. Willems report no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}